Company Filing History:
Years Active: 2010
Title: Innovations of Jennifer Lee Ludington
Introduction
Jennifer Lee Ludington is an accomplished inventor based in Lansdale, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target specific protein kinases. With a total of two patents to her name, her work has implications for treating inflammatory conditions and diseases.
Latest Patents
One of her latest patents is focused on urea inhibitors of MAP kinases. This invention is directed to a compound that has a specific formula, wherein R, R, G, and Q are defined. The compounds developed in this patent are useful as inhibitors of protein kinases, particularly p38 kinases. Additionally, the invention includes compositions that comprise these compounds, which are beneficial for treating and preventing inflammatory conditions. Another notable patent involves substituted piperidines, which are defined by specific formulae. These compounds are particularly suitable as renin inhibitors and exhibit high potency.
Career Highlights
Throughout her career, Jennifer has worked with notable companies such as Locus Pharmaceuticals, Inc. and Speedel Experimenta AG. Her experience in these organizations has allowed her to refine her skills and contribute to innovative projects in the pharmaceutical industry.
Collaborations
Jennifer has collaborated with esteemed colleagues, including Zenon D. Konteatis and Frank Peter Hollinger. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Jennifer Lee Ludington's contributions to the field of biochemistry through her patents and collaborations highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new treatments and therapies.